X0202 SCHEDULE 13G/A 0001608126 XXXXXXXX LIVE 1 Common Stock, $0.01 par value 06/30/2026 0001929561 RXO, Inc. 74982T103 11215 North Community House Road Charlotte NC 28277 Rule 13d-1(b) Finepoint Capital LP DE 0 5355445 0 5355445 5355445 N 3.2 PN IA Herbert Wagner X1 0 5355445 0 5355445 5355445 N 3.2 IN HC RXO, Inc. 11215 North Community House Road, Charlotte, NC 28277 This Amendment No. 1 to Schedule 13G is filed by Finepoint Capital LP ("Finepoint") and Herbert Wagner (each, a "Reporting Person" and together, the "Reporting Persons"). Reference is hereby made to the Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons with respect to the Common Stock of the Issuer on February 13, 2026 (the "Schedule 13G"). Finepoint is a registered investment adviser to certain affiliated funds (the "Funds") that directly hold the securities of the Issuer to which this statement relates for the benefit of their respective investors, and in such capacity Finepoint has voting and dispositive power over such securities. Herbert Wagner is the founder of Finepoint and Managing Partner of FPCap LLC, the general partner of Finepoint, and is responsible for the management of the Funds. The agreement between the Reporting Persons to file the Schedule 13G jointly (the "Joint Filing Agreement") was filed as Exhibit A to the initial filing of the Schedule 13G. 500 Boylston Street, 24th Floor, Boston, MA 02116 Finepoint is a Delaware limited partnership. Herbert Wagner is a citizen of the United States. N IA The information required by this paragraph is set forth in the cover pages to this Schedule 13G/A and is incorporated herein by reference. The information required by this paragraph is set forth in the cover pages to this Schedule 13G/A and is incorporated herein by reference. Percentage ownership is based on 164,920,312 shares of Common Stock outstanding as of May 5, 2026, as reported in the Issuer's Report on Form 10-Q for the period ended March 31, 2026 filed with the Securities and Exchange Commission on May 7, 2026. The information required by this paragraph is set forth in the cover pages to this Schedule 13G/A and is incorporated herein by reference. The information required by this paragraph is set forth in the cover pages to this Schedule 13G/A and is incorporated herein by reference. The information required by this paragraph is set forth in the cover pages to this Schedule 13G/A and is incorporated herein by reference. The information required by this paragraph is set forth in the cover pages to this Schedule 13G/A and is incorporated herein by reference. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Finepoint Capital LP /s/ Stacy L. Vezina 08/13/2026 Herbert Wagner /s/ Herbert Wagner 08/13/2026